| 000 -LEADER |
|---|
| fixed length control field |
01387cam a2200397 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
12783836 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20130310201653.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
020404s2001 sz b i000 0 eng d |
| 010 ## - |
|---|
| -- |
2002422191 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
924154547X |
| 035 ## - |
|---|
| -- |
(OCoLC)ocm49518423 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
B9K |
| Transcribing agency |
B9K |
| Modifying agency |
DLC |
| 042 ## - |
|---|
| -- |
lccopycat |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RA401.A1 |
| 082 00 - |
|---|
| -- |
362.1/782 |
| -- |
21 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
How to develop and implement a national drug policy. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Geneva : |
| Name of publisher, distributor, etc |
World Health Organization, |
| Date of publication, distribution, etc |
c2001. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
viii, 83 p. ; |
| Dimensions |
26 cm. |
| Other physical details |
ill., charts. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Updates and replaces Guidelines for developing national drug policies, 1988. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Bibliography : p. 79-83 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Pharmaceutical policy. |
| 9 (RLIN) |
58279 |
|
|---|
| Topical term or geographic name as entry element |
Drugs, Essential |
| General subdivision |
standards. |
| 9 (RLIN) |
58280 |
|
|---|
| Topical term or geographic name as entry element |
Drug and Narcotic Control. |
| 9 (RLIN) |
58281 |
|
|---|
| Topical term or geographic name as entry element |
Drug Utilization |
| General subdivision |
standards. |
| 9 (RLIN) |
58282 |
|
|---|
| Topical term or geographic name as entry element |
Legislation, Drug. |
| 9 (RLIN) |
58283 |
|
|---|
| Topical term or geographic name as entry element |
Drug Industry |
| General subdivision |
legislation & jurisprudence. |
| 9 (RLIN) |
58284 |
|
|---|
| Topical term or geographic name as entry element |
Health Policy. |
| 9 (RLIN) |
58285 |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization. |
| 9 (RLIN) |
58286 |
| 740 0# - |
|---|
| -- |
Guidelines for developing national drug policies. |
| 906 ## - |
|---|
| -- |
7 |
| -- |
cbc |
| -- |
copycat |
| -- |
3 |
| -- |
ncip |
| -- |
20 |
| -- |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| 955 ## - |
|---|
| -- |
of22 2002-05-21 to SSCD |
| -- |
sf07 2002-06-14 |
| -- |
sf09 to jc00 2002-06-20 |
| -- |
aa05 2002-09-12 |